Finance

Lists
OCGN:NASDAQ
Ocugen Inc
USD 0,79
+0,90%
(+0,0070) 1D
USD 0,79
+0,05% (+0,00040)
Pre-market
Closed: 19 Okt., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OCGN...
Open
USD 0,80
High
USD 0,81
Low
USD 0,78
Mkt. cap
267,08 m
Avg. vol.
8,61 m
Volume
3,03 k
52-wk high
USD 2,72
52-wk low
USD 0,78
EPS
-USD 0,25
Beta
2,27
Shares outstanding
339,11 m
No. of employees
116
Open
USD 0,80
High
USD 0,81
Low
USD 0,78
Mkt. cap
267,08 m
Avg. vol.
8,61 m
Volume
3,03 k
52-wk high
USD 2,72
52-wk low
USD 0,78
EPS
-USD 0,25
Beta
2,27
Shares outstanding
339,11 m
No. of employees
116
News stories
From web sources and news partners
About Ocugen Inc
CEOShankar Musunuri
Employees116
Founded2013
HeadquartersMalvern, Pennsilvanië, Verenigde State van Amerika
Sector-
Websiteocugen.com
Analyst ratings
Based on 5 analysts giving stock ratings to OCGN in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for OCGN in the last 3 months.
Highest
Current USD 0,79
USD 12,00 (+1 424,20%)
Average
USD 10,20 (+1 195,57%)
Lowest
USD 8,00 (+916,13%)
Analyst
Recommendation
Action
Price target
Projected
Date
Swayampakula Ramakanth
H.C. Wainwright
Buy
Reiterated
USD 10,00
+1 170,2%
10/01/2026
Whitney Ijem
Canaccord Genuity
Buy
Maintained
USD 11,00
+1 297,2%
09/29/2026
Leland Gershell
Oppenheimer
Buy
Reiterated
USD 10,00
+1 170,2%
09/29/2026
Robert LeBoyer
Noble Financial
Buy
Reiterated
USD 12,00
+1 424,2%
09/28/2026
Michael Okunewitch
Maxim Group
Buy
Reiterated
USD 8,00
+916,1%
09/16/2026
Daniil Gataulin
Chardan Capital
Buy
Reiterated
USD 7,00
+789,1%
05/07/2026
Elemer Piros
Lucid Capital
Buy
Maintained
USD 22,00
+2 694,4%
03/11/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
1,75 m
-193,00 k
1,53 m
1,49 m
Cost of goods sold
11,15 m
10,67 m
11,26 m
10,69 m
Cost of revenue
11,15 m
10,67 m
11,26 m
10,69 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8,23 m
6,13 m
8,12 m
7,24 m
Operating expense
8,23 m
6,13 m
8,12 m
7,24 m
Total operating expenses
19,38 m
16,80 m
19,37 m
17,93 m
Operating income
-17,62 m
-17,00 m
-17,84 m
-16,44 m
Other non operating income
-1,32 m
477,00 k
-150,00 k
-1,97 m
EBT including unusual items
-20,05 m
-17,71 m
-19,18 m
-24,88 m
EBT excluding unusual items
-20,05 m
-17,71 m
-19,18 m
-22,49 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-20,05 m
-17,71 m
-19,18 m
-24,88 m
Net profit margin
-1 144,46%
9 174,09%
-1 250,95%
-1 671,84%
Earnings per share
-0,07
-0,06
-0,06
-0,06
Interest and investment income
207,00 k
144,00 k
132,00 k
395,00 k
Interest expense
-1,31 m
-1,33 m
-1,32 m
-4,48 m
Net interest expenses
-1,11 m
-1,19 m
-1,19 m
-4,08 m
Depreciation and amortization charges
-
-
-
-
EBITDA
-16,68 m
-16,40 m
-17,25 m
-15,86 m
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme